BioTech Medics, Inc. (BMCS)

BioTech Medics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2011	FY 2008
Period Ending	Dec 31, 2011	Dec 31, 2008
Revenue	0.47	0.48
Revenue Growth (YoY)	-1.47%	-
Cost of Revenue	0.06	0.07
Gross Profit	0.41	0.4
Selling, General & Admin	0.37	0.58
Research & Development	-	0
Other Operating Expenses	-	0.01
Operating Expenses	0.99	0.59
Operating Income	-0.58	-0.18
Other Non Operating Income (Expenses)	-0.02	-
Pretax Income	-0.6	-0.18
Net Income	-0.6	-0.18
Net Income to Common	-0.6	-0.18
Shares Outstanding (Basic)	157	-
Shares Outstanding (Diluted)	157	-
EPS (Basic)	-0.00	-
EPS (Diluted)	-0.00	-
Gross Margin	86.88%	84.34%
Operating Margin	-124.16%	-38.39%
Profit Margin	-128.51%	-38.39%
EBITDA	0.03	-
EBITDA Margin	7.10%	-
D&A For EBITDA	0.62	-
EBIT	-0.58	-0.18
EBIT Margin	-124.16%	-38.39%
Advertising Expenses	-	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.